StockData
Intensity Therapeutics, Inc. logo

Intensity Therapeutics, Inc. (INTS) stock

INTSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.07−0.01 (-0.32%)

Close on Nov 16, 2026Market cap $10.02MP/E –Yield –

Intensity Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Intensity Therapeutics

Intensity Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Intensity Therapeutics figures

See a number that looks wrong?